FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095687014> ?p ?o ?g. }

• W2095687014 endingPage "8379" @default.
• W2095687014 startingPage "8371" @default.
• W2095687014 abstract "Ifosfamide, carboplatin, etoposide, and vincristine, alone and in combination, are highly active against small-cell lung cancer (SCLC). This trial was designed to investigate whether survival could be improved by a regimen of all four drugs (ICE-V) compared with standard chemotherapy in patients with SCLC and good performance status, and to assess the patients' quality of life (QL).Patients were randomly assigned to receive six cycles of either ICE-V at 4-week intervals without dose reduction or standard chemotherapy administered according to local practice. The recommended standard control regimens were cyclophosphamide, doxorubicin, and etoposide; and cisplatin and etoposide.A total of 402 patients were randomly assigned, and 350 (87%) patients have died. Overall survival was longer in the ICE-V group (hazard ratio, 0.74; 95% CI, 0.60 to 0.91; P = .0049), median survival was 15.6 months in the ICE-V group and 11.6 months in the control group, and 2-year survival rates were 20% and 11%, respectively. There was no evidence that the relative survival benefit for ICE-V was less in extensive-stage than in limited-stage patients. An increased rate of septicemia was reported in the ICE-V group (15% v 7% in the control group), but this did not result in an increase in reported treatment-related deaths (four patients [2%] in both groups). The findings on QL were broadly similar in both groups, with some benefit in favor of ICE-V.Compared with standard chemotherapy, the ICE-V regimen improves overall survival without QL penalties, despite an increased but manageable level of toxicity." @default.
• W2095687014 created "2016-06-24" @default.
• W2095687014 creator A5001475020 @default.
• W2095687014 creator A5005515698 @default.
• W2095687014 creator A5008290466 @default.
• W2095687014 creator A5024744790 @default.
• W2095687014 creator A5025460339 @default.
• W2095687014 creator A5047637104 @default.
• W2095687014 creator A5077378238 @default.
• W2095687014 creator A5081504508 @default.
• W2095687014 date "2005-11-20" @default.
• W2095687014 modified "2023-10-01" @default.
• W2095687014 title "Ifosfamide, Carboplatin, and Etoposide With Midcycle Vincristine Versus Standard Chemotherapy in Patients With Small-Cell Lung Cancer and Good Performance Status: Clinical and Quality-of-Life Results of the British Medical Research Council Multicenter Randomized LU21 Trial" @default.
• W2095687014 cites W1495781375 @default.
• W2095687014 cites W1885320430 @default.
• W2095687014 cites W1898563448 @default.
• W2095687014 cites W1903188031 @default.
• W2095687014 cites W1905406155 @default.
• W2095687014 cites W1920090590 @default.
• W2095687014 cites W1970325604 @default.
• W2095687014 cites W1973510243 @default.
• W2095687014 cites W1992291788 @default.
• W2095687014 cites W1995546443 @default.
• W2095687014 cites W1998172322 @default.
• W2095687014 cites W1998962333 @default.
• W2095687014 cites W2016103375 @default.
• W2095687014 cites W2024594137 @default.
• W2095687014 cites W2055939633 @default.
• W2095687014 cites W2061402383 @default.
• W2095687014 cites W2073683299 @default.
• W2095687014 cites W2097597328 @default.
• W2095687014 cites W2105847144 @default.
• W2095687014 cites W2109567704 @default.
• W2095687014 cites W2123581060 @default.
• W2095687014 cites W2123701436 @default.
• W2095687014 cites W2123767004 @default.
• W2095687014 cites W2128175002 @default.
• W2095687014 cites W2150878803 @default.
• W2095687014 cites W2151177054 @default.
• W2095687014 cites W2158049870 @default.
• W2095687014 cites W2160012348 @default.
• W2095687014 cites W2166281097 @default.
• W2095687014 cites W2167571044 @default.
• W2095687014 cites W2168946802 @default.
• W2095687014 cites W2173643829 @default.
• W2095687014 cites W2224378565 @default.
• W2095687014 cites W2248341615 @default.
• W2095687014 cites W2341745217 @default.
• W2095687014 cites W296967391 @default.
• W2095687014 cites W4237767730 @default.
• W2095687014 doi "https://doi.org/10.1200/jco.2004.00.9969" @default.
• W2095687014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16293867" @default.
• W2095687014 hasPublicationYear "2005" @default.
• W2095687014 type Work @default.
• W2095687014 sameAs 2095687014 @default.
• W2095687014 citedByCount "51" @default.
• W2095687014 countsByYear W20956870142012 @default.
• W2095687014 countsByYear W20956870142013 @default.
• W2095687014 countsByYear W20956870142014 @default.
• W2095687014 countsByYear W20956870142015 @default.
• W2095687014 countsByYear W20956870142016 @default.
• W2095687014 countsByYear W20956870142017 @default.
• W2095687014 countsByYear W20956870142018 @default.
• W2095687014 countsByYear W20956870142019 @default.
• W2095687014 countsByYear W20956870142022 @default.
• W2095687014 countsByYear W20956870142023 @default.
• W2095687014 crossrefType "journal-article" @default.
• W2095687014 hasAuthorship W2095687014A5001475020 @default.
• W2095687014 hasAuthorship W2095687014A5005515698 @default.
• W2095687014 hasAuthorship W2095687014A5008290466 @default.
• W2095687014 hasAuthorship W2095687014A5024744790 @default.
• W2095687014 hasAuthorship W2095687014A5025460339 @default.
• W2095687014 hasAuthorship W2095687014A5047637104 @default.
• W2095687014 hasAuthorship W2095687014A5077378238 @default.
• W2095687014 hasAuthorship W2095687014A5081504508 @default.
• W2095687014 hasConcept C121608353 @default.
• W2095687014 hasConcept C126322002 @default.
• W2095687014 hasConcept C126894567 @default.
• W2095687014 hasConcept C141071460 @default.
• W2095687014 hasConcept C143998085 @default.
• W2095687014 hasConcept C207103383 @default.
• W2095687014 hasConcept C2776256026 @default.
• W2095687014 hasConcept C2776694085 @default.
• W2095687014 hasConcept C2776755627 @default.
• W2095687014 hasConcept C2777506904 @default.
• W2095687014 hasConcept C2778119113 @default.
• W2095687014 hasConcept C2778239845 @default.
• W2095687014 hasConcept C2779429289 @default.
• W2095687014 hasConcept C2780352672 @default.
• W2095687014 hasConcept C2781413609 @default.
• W2095687014 hasConcept C2781451048 @default.
• W2095687014 hasConcept C44249647 @default.
• W2095687014 hasConcept C71924100 @default.
• W2095687014 hasConceptScore W2095687014C121608353 @default.
• W2095687014 hasConceptScore W2095687014C126322002 @default.
• W2095687014 hasConceptScore W2095687014C126894567 @default.
• W2095687014 hasConceptScore W2095687014C141071460 @default.
• W2095687014 hasConceptScore W2095687014C143998085 @default.

• next